F Saia

Summary

Publications

  1. ncbi request reprint Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study
    Francesco Saia
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:455-60. 2004
  2. ncbi request reprint Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions
    Angela Hoye
    Department of Interventional Cardiology, Erasmus MC, Rotterdam, The Netherlands
    J Am Coll Cardiol 43:1954-8. 2004
  3. ncbi request reprint Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy Electronic address
    Int J Cardiol 168:1034-40. 2013
  4. doi request reprint Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    EuroIntervention 8:1388-97. 2013
  5. doi request reprint Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Catheter Cardiovasc Interv 79:712-9. 2012
  6. doi request reprint Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality
    F Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi Pad 21, Bologna, Italy
    Heart 95:370-6. 2009
  7. ncbi request reprint Drug-eluting stents. The third revolution in percutaneous coronary intervention
    Francesco Saia
    Department of Interventional Cardiology, Erasmus Medical Center Thoraxcenter, Rotterdam, The Netherlands
    Ital Heart J 6:289-303. 2005
  8. ncbi request reprint Emergency balloon aortic valvuloplasty in patients with critical aortic stenosis presenting with cardiogenic shock
    Francesco Saia
    Catheterization Laboratory, Institute of Cardiology, University of Bologna, Bologna, Italy
    Ital Heart J 6:420-3. 2005
  9. ncbi request reprint Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods
    Francesco Saia
    Department of Interventional Cardiology, Erasmus Medical Centre, Thoraxcentre, Rotterdam, The Netherlands
    J Cardiovasc Med (Hagerstown) 7:21-8. 2006
  10. doi request reprint The safety of drug-eluting stents
    Francesco Saia
    Institute of Cardiology University of Bologna, Policlinico S Orsola Malpighi Pad 21, Via Massarenti, 9, 40138 Bologna Italy
    Ther Adv Cardiovasc Dis 2:43-52. 2008

Collaborators

Detail Information

Publications76

  1. ncbi request reprint Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study
    Francesco Saia
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:455-60. 2004
    ..13 +/- 0.34 and restenosis rate was 7.7%. Although not routinely recommended in every patient, SES postdilatation with largely oversized balloons appears a safe and effective strategy for selected patients...
  2. ncbi request reprint Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions
    Angela Hoye
    Department of Interventional Cardiology, Erasmus MC, Rotterdam, The Netherlands
    J Am Coll Cardiol 43:1954-8. 2004
    ..The aim of this study was to assess sirolimus-eluting stent (SES) implantation for the treatment of chronic total coronary occlusions (CTO)...
  3. ncbi request reprint Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy Electronic address
    Int J Cardiol 168:1034-40. 2013
    ..Limited data exist on renal complications of transcatheter aortic valve implantation (TAVI) within a comprehensive program using different valves with transfemoral, transapical, and trans-subclavian approach...
  4. doi request reprint Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    EuroIntervention 8:1388-97. 2013
    ..This study describes the indications and long-term outcome of balloon aortic valvuloplasty (BAV) in recent years...
  5. doi request reprint Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Catheter Cardiovasc Interv 79:712-9. 2012
    ..To ascertain incidence and predictors of new permanent pacemaker (PPM) following transcatheter aortic valve implantation (TAVI) with the self-expanding aortic bioprosthesis...
  6. doi request reprint Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality
    F Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi Pad 21, Bologna, Italy
    Heart 95:370-6. 2009
    ..To assess the clinical impact of a regional network for the treatment of ST-segment elevation myocardial infarction (STEMI)...
  7. ncbi request reprint Drug-eluting stents. The third revolution in percutaneous coronary intervention
    Francesco Saia
    Department of Interventional Cardiology, Erasmus Medical Center Thoraxcenter, Rotterdam, The Netherlands
    Ital Heart J 6:289-303. 2005
    ..For the marketed stents, we also report the results of the first clinical evaluations in real life and a few insights into the most controversial issues...
  8. ncbi request reprint Emergency balloon aortic valvuloplasty in patients with critical aortic stenosis presenting with cardiogenic shock
    Francesco Saia
    Catheterization Laboratory, Institute of Cardiology, University of Bologna, Bologna, Italy
    Ital Heart J 6:420-3. 2005
    ....
  9. ncbi request reprint Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods
    Francesco Saia
    Department of Interventional Cardiology, Erasmus Medical Centre, Thoraxcentre, Rotterdam, The Netherlands
    J Cardiovasc Med (Hagerstown) 7:21-8. 2006
    ..This current perspective describes the recently developed invasive imaging techniques to detect atherosclerotic vulnerable plaques in the coronary tree...
  10. doi request reprint The safety of drug-eluting stents
    Francesco Saia
    Institute of Cardiology University of Bologna, Policlinico S Orsola Malpighi Pad 21, Via Massarenti, 9, 40138 Bologna Italy
    Ther Adv Cardiovasc Dis 2:43-52. 2008
    ..In this article, we reviewed the most recent information to clarify the conundrum of late stent thrombosis and the long-term safety of DES...
  11. ncbi request reprint Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry
    Francesco Saia
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Italy
    EuroIntervention 5:57-66. 2009
    ..To evaluate the long-term clinical outcome after drug-eluting stents (DES) implantation, and to test if patient selection could enhance their net clinical benefit...
  12. doi request reprint How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation?
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    J Cardiovasc Med (Hagerstown) 11:727-32. 2010
    ..We sought to assess what proportion of patients with severe symptomatic aortic stenosis who are excluded from cardiac surgery are eligible for transcatheter aortic valve implantation (TAVI)...
  13. doi request reprint Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Am Heart J 160:S16-21. 2010
    ..In this review, we provide a practical diagnostic and therapeutic algorithm that may be helpful for the clinical management of patients with acute LV failure after primary PCI...
  14. doi request reprint Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation?
    Francesco Saia
    Department of Cardiovascular Diseases, Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Catheter Cardiovasc Interv 79:315-21. 2012
    ..To assess safety and effectiveness of balloon aortic valvuloplasty (BAV) in patients with symptomatic severe aortic stenosis (AS) and significant aortic regurgitation...
  15. ncbi request reprint Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi Pad 21, Via Massarenti, 9, 40138 Bologna, Italy
    J Invasive Cardiol 23:E106-9. 2011
    ..Angiographic and intravascular ultrasound findings at follow-up are reported. This case describes one of the mechanisms of a dreadful complication of TAVI and its difficult management...
  16. doi request reprint Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Via Massarenti 40138 Bologna, Italy
    Future Cardiol 7:321-31. 2011
    ..Awareness of the mechanisms behind these complications might help in their prevention, recognition and management and may ultimately improve the clinical outcome of TAVI procedures...
  17. doi request reprint The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation
    Francesco Saia
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    EuroIntervention 7:723-9. 2011
    ..Many inoperable patients with severe aortic stenosis (AS) are not immediately eligible for transcatheter aortic valve implantation (TAVI). We evaluated the role of percutaneous balloon aortic valvuloplasty (BAV) in this setting...
  18. ncbi request reprint Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry
    Francesco Saia
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    J Am Coll Cardiol 48:1312-8. 2006
    ..We compared the clinical outcome of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in a real-world scenario...
  19. doi request reprint Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction
    Francesco Saia
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Italy
    Acute Card Care 12:42-50. 2010
    ....
  20. ncbi request reprint Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events
    Antonio Marzocchi
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Am J Cardiol 95:1409-14. 2005
    ....
  21. ncbi request reprint Drug-eluting stents: from randomized trials to the real world
    F Saia
    Catheterization Laboratory, Institute of Cardiology, University of Bologna, Bologna, Italy
    Minerva Cardioangiol 52:349-63. 2004
    ..In this review we describe the main clinical trials on drug-eluting stents, and the most recent informations derived from observational studies and registries. Moreover, preliminary results on new drug-eluting stents are summarized...
  22. ncbi request reprint Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry
    Antonio Marzocchi
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Circulation 115:3181-8. 2007
    ..The long-term safety and efficacy of drug-eluting stents (DES) have been questioned recently...
  23. pmc Long term outcome after intracoronary beta radiation therapy
    G Sianos
    Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    Heart 91:942-7. 2005
    ..To determine the long term outcome after intracoronary beta radiation therapy (IRT)...
  24. ncbi request reprint Coronary stenting for unstable angina: predictors of 30-day and long-term clinical outcome
    A Marzocchi
    Institute of Cardiology, University of Bologna, Italy
    Coron Artery Dis 10:81-8. 1999
    ..This study sought to evaluate the results of coronary stenting in unstable angina and to determine patient, lesion and procedure-related predictors of 30-day and long-term ischemic events...
  25. doi request reprint Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry
    Paolo Ortolani
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Via Massarenti 9, 40138, Bologna, Italy
    Circulation 117:923-30. 2008
    ..The long-term effectiveness of drug-eluting stents (DES) in unselected diabetics in routine practice is currently unclear...
  26. ncbi request reprint Ultrasound-assisted stent implantation in small size coronary arteries: a pilot study
    P Ortolani
    Institute of Cardiology, University of Bologna, Italy
    Ital Heart J 2:372-8. 2001
    ..The aim of this pilot study was to evaluate the feasibility and safety of IVUS imaging of small vessels. Secondary endpoints were the immediate and long-term results of IVUS-guided elective BeStent implantation in small vessels...
  27. ncbi request reprint Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina
    Paolo Ortolani
    Institute of Cardiology, University of Bologna, Bologna, Italy
    Ital Heart J 5:189-96. 2004
    ..We prospectively investigated whether plasma homocysteine (HCY) concentrations are related to target lesion revascularization (TLR) rates in patients with unstable angina undergoing stenting...
  28. ncbi request reprint Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings
    Kengo Tanabe
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 94:115-8. 2004
    ..At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis...
  29. doi request reprint Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice
    M Masetti
    Cardiovascular Department of the University of Bologna, Bologna, Italy
    Am J Transplant 13:1217-26. 2013
    ....
  30. ncbi request reprint Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 109:1366-70. 2004
    ..The factors associated with the occurrence of restenosis after sirolimus-eluting stent (SES) implantation in complex cases are currently unknown...
  31. ncbi request reprint Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization
    Paolo Ortolani
    Institute of Cardiology, S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Catheter Cardiovasc Interv 69:790-8. 2007
    ..To see whether use of a sirolimus-eluting stent (SES) is superior to a third-generation thin-strut, cobalt-chromium stent (CCS) in terms of in-segment late loss at 9 months in patients with symptomatic coronary artery disease...
  32. ncbi request reprint Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery
    Angela Hoye
    Department of Cardiology, Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands
    Coron Artery Dis 15:171-5. 2004
    ..We evaluated the impact of utilizing the sirolimus-eluting stent (SES) in this high-risk population...
  33. ncbi request reprint Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
    Paolo Ortolani
    Institute of Cardiology, S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Am J Cardiol 100:787-92. 2007
    ....
  34. ncbi request reprint Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study
    Francesco Saia
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 108:1927-9. 2003
    ..Sirolimus-eluting stents (SES) have recently been proven to reduce restenosis and reintervention compared with bare stents. Safety and effectiveness of SES in acute myocardial infarction remain unknown...
  35. pmc Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS)
    C H Lee
    Erasmus Medical Centre, Thoraxcentre, Rotterdam, The Netherlands
    Heart 90:1156-61. 2004
    ..To investigate the effect on risk of major adverse cardiac events (MACE) of lipid lowering treatment with fluvastatin 80 mg/day after a first percutaneous coronary intervention in patients with stable and unstable angina...
  36. ncbi request reprint Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease
    Chourmouzios A Arampatzis
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 92:327-9. 2003
    ..The implantation of this stent was associated with abolition of post-discharge fatal events and percutaneous reintervention...
  37. ncbi request reprint Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 109:190-5. 2004
    ..The effectiveness of sirolimus-eluting stents in unselected patients treated in the daily practice is currently unknown...
  38. ncbi request reprint Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis
    Tullio Palmerini
    Istituto di Cardiologia, Policlinico S Orsola, Universita di Bologna, 40 138 Bologna, Italy
    Circulation 112:2332-8. 2005
    ..We examined the predictive value of preprocedural levels of C-reactive protein (CRP), fibrinogen, and leukocyte counts with respect to 9-month clinical outcomes after stenting of the ULMCA stenosis...
  39. ncbi request reprint Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation
    Francesco Saia
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 93:92-5. 2004
    ..4, p = 0.03)...
  40. pmc Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry
    F Saia
    Department of Invasive Cardiology, Thoraxcentre, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Heart 90:1183-8. 2004
    ....
  41. ncbi request reprint Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry)
    Pedro A Lemos
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Am J Cardiol 93:633-6. 2004
    ..7% versus 3.9%, respectively (p = 0.1). The 12-month target lesion revascularization rate was 5.5%. In conclusion, 2.25-mm SESs were associated with low rates of clinical and angiographic late complications...
  42. ncbi request reprint Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention
    Paolo Ortolani
    Institute of Cardiology, Azienda Ospedaliera S Orsola Malpighi Hospital, University of Bologna, Via Massarenti 9, Bologna 40138, Italy
    Eur Heart J 29:1241-9. 2008
    ..To evaluate the predictive value of high sensitivity (hs) C-reactive protein levels on long-term survival in patients with ST-elevation myocardial infarction (STEMI) treated with primary PCI...
  43. ncbi request reprint Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameter
    Angela Hoye
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 94:112-4. 2004
    ..At a mean follow-up of 399 +/- 120 days, the survival-free of major adverse events was 95%, with no patient requiring target lesion revascularization...
  44. ncbi request reprint Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome
    Chourmouzios A Arampatzis
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 62:292-6; discussion 297. 2004
    ..04 +/- 0.65 mm and one focal restenosis (8% of patients). Elective SES implantation for LM disease was associated with zero mortality and a very low incidence of additional major adverse events at 1 year...
  45. doi request reprint Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network
    Paolo Ortolani
    Institute of Cardiology, S Orsola Malpighi Hospital, University of Bologna, Via Massarenti, Bologna, Italy
    Eur Heart J 30:33-43. 2009
    ..To evaluate the clinical impact of early administration of glycoprotein IIb/IIIa agents (IIb/IIIa agents) in the context of a dedicated hub and spoke network allowing very prompt pharmacological/mechanical interventions...
  46. ncbi request reprint Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience
    Chourmouzios A Arampatzis
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 63:57-60. 2004
    ..6%. SES implantation for multivessel disease in a consecutive series of patients is associated with low incidence of adverse events. The reported results are related predominantly to the reduction in repeat revascularization...
  47. ncbi request reprint Very long sirolimus-eluting stent implantation for de novo coronary lesions
    Muzaffer Degertekin
    Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    Am J Cardiol 93:826-9. 2004
    ..1%), and the overall incidence of major cardiac events was 8.3%. Thus, SES implantation appears safe and effective for de novo coronary lesions requiring multiple stent placement over a very long vessel segment...
  48. ncbi request reprint Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy
    Chourmouzios A Arampatzis
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Am Heart J 149:329-35. 2005
    ..The aim of this study was to determine the clinical benefit of long-term fluvastatin in patients with diabetes who had undergone a successful PCI...
  49. ncbi request reprint Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study
    Ron T van Domburg
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Thorac Surg 79:1563-9. 2005
    ..Therefore, we evaluated the 8-year outcome after multivessel stent implantation (stent group) or coronary artery bypass surgery (CABG group) in a single-center propensity-matched cohort study...
  50. ncbi request reprint Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis
    Francesco Saia
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 62:283-8. 2004
    ..1% VBT vs. 81.5% SES; P = 0.8 by log rank). The result of this nonrandomized study suggests that sirolimus-eluting stent implantation is at least as effective as vascular brachytherapy in the treatment of in-stent restenosis...
  51. ncbi request reprint Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction
    Paolo Ortolani
    Institute of Cardiology, Azienda Ospedaliera S Orsola Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy
    Eur Heart J 27:1550-7. 2006
    ..We investigated effectiveness of pre-hospital diagnosis of STEMI with direct referral to PCI, alongside more conventional referral strategies...
  52. doi request reprint Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial
    Antonio Marzocchi
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Via Massarenti, 9, Bologna 40138, Italy
    Eur Heart J 29:2972-80. 2008
    ..To test the equivalence of high-dose bolus (HDB) tirofiban vs. abciximab during primary percutaneous coronary intervention (PPCI) in terms of ST-segment resolution (STR)...
  53. ncbi request reprint Stent fracture and restenosis in the drug-eluting stent era
    Georgios Sianos
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:111-6. 2004
  54. ncbi request reprint Noninvasive assessment of coronary plaque burden using multislice computed tomography
    Nico R Mollet
    Department of Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 95:1165-9. 2005
    ..Overall, 65% of plaques were calcified, 24% were noncalcified, and 11% were mixed. Plaques were predominantly located in the proximal and middle segments of the main coronary vessels...
  55. ncbi request reprint Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 95:445-51. 2005
    ..The benefit of fluvastatin was unrelated to any effect on renal function...
  56. ncbi request reprint Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease
    Angela Hoye
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invasive Cardiol 16:230-3. 2004
    ..Increased utilization of distal protection devices might reduce the peri-procedural rate of AMI...
  57. ncbi request reprint Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction
    Paolo Ortolani
    Institute of Cardiology, S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Am Heart J 154:366-72. 2007
    ..The objective of this study was to evaluate this issue in a more recent population of patients with STEMI treated with PPCI in a high-volume tertiary center specifically dedicated to STEMI treatment...
  58. doi request reprint Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)
    Nevio Taglieri
    Istituto di Cardiologia, Universita di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Am J Cardiol 103:785-90. 2009
    ..Preprocedure Thrombolysis In Myocardial Infarction flow grade >0 seems to be the most important predictor of favorable LVEF and LV function recovery at 30 days...
  59. ncbi request reprint Long-term outcome of percutaneous coronary interventions following failed beta-brachytherapy
    Francesco Saia
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invasive Cardiol 16:60-4. 2004
    ..The long-term outcome of repeat percutaneous intervention (PCI) after failed beta-brachytherapy is currently unknown...
  60. doi request reprint The conundrum of transient cortical blindness following coronary angiography
    Claudia Borghi
    Institute of Cardiology, University of Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    J Cardiovasc Med (Hagerstown) 9:1063-5. 2008
    ..The outcome is generally favourable, with spontaneous return of sight within 24-48 h and no requirement for specific therapy. Recurrence has never been reported...
  61. ncbi request reprint Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry)
    Tullio Palmerini
    Istituto di Cardiologia, Policlinico S Orsola, University of Bologna, Bologna, Italy
    Am J Cardiol 98:54-9. 2006
    ..However, the rate of target lesion revascularization was higher in the PCI group...
  62. ncbi request reprint [A dangerous "appendix"]
    Alessandro Marinelli
    Istituto di Cardiologia, Universita degli Studi, Policlinico S Orsola Malpighi, Bologna
    G Ital Cardiol (Rome) 9:425-6. 2008
  63. ncbi request reprint [Pitfalls of cardiologic consultation in internal medicine: an obvious case of alcoholic liver cirrhosis]
    Elena Biagini
    Istituto di Cardiologia, Universita degli Studi, Policlinico S Orsola Malpighi, Bologna
    G Ital Cardiol (Rome) 9:199-204. 2008
  64. ncbi request reprint Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, Netherlands
    J Am Coll Cardiol 43:704-8. 2004
    ..This study investigated the clinical outcomes of patients with ST-segment elevation myocardial infarction (MI) treated with sirolimus-eluting stents (SESs) or with conventional bare stents...
  65. ncbi request reprint Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients
    Evelyn Regar
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Am J Cardiol 93:1271-5. 2004
    ..These cases occurred in diabetic women with complex coronary lesions. Intravascular ultrasound examination showed inadequate stent expansion and uncovered distal dissection as possible mechanical explanations for the thrombosis...
  66. ncbi request reprint Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry
    Pedro A Lemos
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Dr Molewaterplein 40, NL 3015 GD Rotterdam, The Netherlands
    J Am Coll Cardiol 41:2093-9. 2003
    ..This study evaluated the early outcomes of patients with acute coronary syndromes (ACS) treated with sirolimus-eluting stents (SES)...
  67. ncbi request reprint Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Bd 406, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Circulation 108:257-60. 2003
    ..We describe the clinical and morphological patterns of restenosis after sirolimus-eluting stent (SES) implantation...
  68. ncbi request reprint Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, Netherlands
    Int J Cardiol 98:479-86. 2005
    ..To evaluate the impact of the extent of coronary disease (single- or multivessel) and of fluvastatin treatment on the incidence of long-term cardiac atherosclerotic complications in the Lescol Intervention Prevention Study (LIPS)...
  69. ncbi request reprint Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus
    Heleen M M van Beusekom
    Department of Cardiology, Ee 2355b, Erasmus Medical Center Rotterdam, Dr Molewaterplein 50, PO Box 1738, 3000 Rotterdam, The Netherlands
    Eur Heart J 28:974-9. 2007
    ....
  70. ncbi request reprint Incidence of high-strain patterns in human coronary arteries: assessment with three-dimensional intravascular palpography and correlation with clinical presentation
    Johannes A Schaar
    Erasmus Medical Center, Thoraxcenter Rotterdam, Kamer Ee 23 32, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Circulation 109:2716-9. 2004
    ..We further explored the relation of such regions to clinical presentation and to C-reactive protein levels...
  71. ncbi request reprint Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents
    Pedro A Lemos
    Heart Institute InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Am J Cardiol 95:167-72. 2005
    ..It seems unlikely that restenosis could be a contributing factor that influenced the increased mortality of patients who had impaired renal function...
  72. ncbi request reprint Safety and long-term efficacy of sirolimus eluting stent in ST-elevation acute myocardial infarction: the REAL (Registro REgionale AngiopLastiche Emilia-Romagna) registry
    Gianfranco Percoco
    Unità di Cardiologia, Universita di Ferrara, Ospedale S Anna Ferrara, Ferrara
    Cardiovasc Drugs Ther 20:63-8. 2006
    ..Limited data are available for sirolimus eluting stent (SES) implantation in patients with ST-segment elevation myocardial infarction (STEMI)...
  73. ncbi request reprint Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy
    Francesco Saia
    Erasmus MC, Thoraxcenter, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Am J Cardiol 92:200-3. 2003
  74. ncbi request reprint Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris
    Nico R Mollet
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands
    J Am Coll Cardiol 43:2265-70. 2004
    ....
  75. doi request reprint Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry)
    Luigi Vignali
    Division of Cardiology, Azienda Ospedaliero Universitaria, Parma, Italy
    Am J Cardiol 101:947-52. 2008
    ..In conclusion, our data suggest that rates of 12-month MACEs associated with the use of DESs and BMSs are similar in patients undergoing treatment of de novo lesions in SVGs...
  76. ncbi request reprint Fluvastatin reduces cardiac mortality in patients with coronary heart disease
    Christie M Ballantyne
    Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Cardiovasc Drugs Ther 18:67-75. 2004
    ..To test the effectiveness of fluvastatin, 40-80 mg, in reducing the occurrence of cardiac and all-cause mortality in patients with coronary heart disease (CHD)...